Collagen News and Research

Latest Collagen News and Research

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.

4 Nov 2009

Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL

Cardium Therapeutics today announced plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL(TM) product candidate.

3 Nov 2009

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

Helix BioMedix, Inc., a developer of bioactive peptides, today announced the completion of a series of three clinical studies investigating the safety and efficacy of a serum, eye cream and moisturizer, each containing the Company’s SmartPeptides™ technology, including the newly developed Heptapeptide-7. These studies demonstrate improvement in skin texture and appearance as well as the decrease in fine lines and wrinkles with Striking™ Skin Care formulations.

28 Oct 2009

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today that Alnylam has granted KOKEN a non-exclusive worldwide license to manufacture and provide RNAi research products and services under the Kreutzer-Limmer patent family.

27 Oct 2009

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, announced today that it has reached an agreement with Biocure S.r.l. of Milan, Italy for the distribution of WNDM's patented molecular form of activated collagen, CellerateRx®.

26 Oct 2009

STAAR Surgical Company reports promising assessments from CAST

STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project.

26 Oct 2009

VASER-Assisted Lipoplasty delivers superior results in skin retraction and blood loss

At the 78th Annual American Society of Plastic Surgeons Annual (ASPS) Meeting, Dr. Paul Vanek presented a study that confirms that VASER-Assisted Lipoplasty (VAL) delivers superior results over traditional Suction-Assisted Lipoplasty (SAL) in skin retraction and blood loss.

26 Oct 2009

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, “A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial,” at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).

24 Oct 2009

First-quarter fiscal 2010 results announced by Kensey Nash

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2009.

22 Oct 2009

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

A group led by Dr. Dieter Br-mme at the University of British Columbia has demonstrated that glycosaminoglycans (GAGs) contribute to skeletal abnormalities in patients with lysosomal storage diseases. Their report can be found in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

Non-invasive tool to increase facial volume and reverse some of the visible signs of aging

Faces don't lie when it comes to showing signs of aging. Yet gravity alone is not the sole determinant of the aging face. Studies have demonstrated that volume loss of soft tissue and bone is at least equally important to facial aging. The loss of volume in the face over time can cause deep lines, sunken areas around the eyes, temples, nose and jowls.

20 Oct 2009

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Cardium Therapeutics today announced the publication of positive findings from the open label multi-center Phase 1/2 clinical study of Excellarate(TM) (GAM501, Ad5PDGF-B / 2.6% collagen), its product candidate for the potential treatment of non-healing diabetic foot ulcers.

19 Oct 2009

National Science Foundation funded 2009 Nobel laureates felicitated

The National Science Foundation (NSF) congratulates the 2009 Nobel laureates, particularly those who have received NSF funding over the years: Jack W. Szostak, who shared the prize in physiology or medicine; Thomas A. Steitz, who shared the prize in chemistry; and Elinor Ostrom and Oliver E. Williamson who earned the Sveriges Riksbank Prize in economic sciences in memory of Alfred Nobel 2009.

15 Oct 2009

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.

15 Oct 2009

Medtronic announces results of study comparing INFUSE Bone Graft to autogenous bone graft

Medtronic, Inc. today announced results of a study comparing the safety and effectiveness of INFUSE® Bone Graft to autogenous bone graft (bone harvested from the patient) when used in maxillary sinus floor augmentation.

14 Oct 2009

Novasys Medical's Renessa named the most promising new product for 2009

Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that its Renessa® non-surgical treatment for female stress urinary incontinence (SUI) was inducted into the Phoenix Hall of Fame as the 2009 Most Promising New Product at the Phoenix Medical Device and Diagnostic Conference for Chief Executive Officers.

14 Oct 2009

Systagenix Wound Management forms new global Medical Advisory Board

Systagenix Wound Management has announced the formation of a new global Medical Advisory Board, consisting of a group of multi-disciplinary and highly respected wound care clinicians and practitioners from North America and Europe, which will be led by Systagenix's newly appointed Medical Director, Dr Robert Snyder.

13 Oct 2009

VirtualHealth Technologies, Wound Care Innovations enter licensing agreement to use Cifra healthcare platform

VirtualHealth Technologies, Inc., a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today that its subsidiary Secure eHealth has entered into an agreement with Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies Inc., to use its Cifra secure healthcare platform.

12 Oct 2009

Cifra healthcare platform from Wound Management Technologies

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra(TM) healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx® products in managing all types of wound care.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

Collagen News and Research

Latest Collagen News and Research

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

KOKEN receives license to manufacture and provide RNAi research products under Kreutzer-Limmer patent family

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

STAAR Surgical Company reports promising assessments from CAST

VASER-Assisted Lipoplasty delivers superior results in skin retraction and blood loss

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

First-quarter fiscal 2010 results announced by Kensey Nash

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

Non-invasive tool to increase facial volume and reverse some of the visible signs of aging

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

National Science Foundation funded 2009 Nobel laureates felicitated

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Medtronic announces results of study comparing INFUSE Bone Graft to autogenous bone graft

Novasys Medical's Renessa named the most promising new product for 2009

Systagenix Wound Management forms new global Medical Advisory Board

VirtualHealth Technologies, Wound Care Innovations enter licensing agreement to use Cifra healthcare platform

Cifra healthcare platform from Wound Management Technologies

New technique may lead to more effective treatment for liver disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Collagen News and Research

Latest Collagen News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in